ABN AMRO Bank’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,019
Closed -$445K 240
2025
Q3
$445K Hold
6,019
﹤0.01% 206
2025
Q2
$784K Sell
6,019
-709
-11% -$103K 0.01% 127
2025
Q1
$1.07M Buy
6,728
+281
+4% +$50.8K 0.01% 120
2024
Q4
$1.18M Sell
6,447
-274
-4% -$53.2K 0.02% 121
2024
Q3
$1.41M Buy
6,721
+50
+0.7% +$8.69K 0.02% 113
2024
Q2
$900K Sell
6,671
-748
-10% -$142K 0.01% 111
2024
Q1
$1.59M Sell
7,419
-517
-7% -$101K 0.02% 97
2023
Q4
$1.62M Sell
7,936
-3,223
-29% -$522K 0.03% 96
2023
Q3
$2.22M Sell
11,159
-5,175
-32% -$1.31M 0.04% 85
2023
Q2
$5.3M Sell
16,334
-1,816
-10% -$519K 0.11% 60
2023
Q1
$4.26M Buy
+18,150
New +$4.59M 0.1% 67

Other funds holding INSP

ABN AMRO Bank's INSP Position: Q4 2025 in Review

ABN AMRO Bank sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 6,019 shares — an estimated $445K sold.

ABN AMRO Bank first reported a position in INSP in Q1 2023 and held it in 11 quarters. The position peaked at $5.3M in Q2 2023. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • ABN AMRO Bank reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • ABN AMRO Bank sold 6,019 Inspire Medical Systems shares in Q4 2025, an estimated $445K.
  • ABN AMRO Bank first reported a position in Inspire Medical Systems in Q1 2023 and held it in 11 quarters.
  • ABN AMRO Bank's Inspire Medical Systems position peaked at $5.3M in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on ABN AMRO Bank's 13F filing for Q4 2025, filed 4 Feb 2026.